Disc Medicine IRON Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $188.78M+87.4% | $170.64M+76.5% | $149.21M+58.0% | $123.56M+46.8% | $100.73M+38.4% | ||
| $76.82M+105% | $65.38M+97.8% | $54.39M+89.1% | $45.2M+73.5% | $37.47M+55.1% | ||
| $265.6M+92.2% | $236.02M+81.9% | $203.6M+63.0% | $168.76M+52.1% | $138.2M+41.8% | ||
| $3.55M+142% | $3.61M+531% | $3.3M— | $2.38M— | $1.47M— | ||
| $24.29M+9.5% | $24.2M+16.8% | $22.94M+6.1% | $23.84M+18.6% | $22.18M+30.9% | ||
| $293K-37.5% | $361K+1.7% | $449K+113% | $461K+294% | $469K+479% | ||
| -$241.6M-107% | -$212.18M-94.0% | -$181.11M-75.0% | -$145.39M-59.8% | -$116.49M-44.5% | ||
| -$6.62-68.9% | -$5.99-50.1% | -$5.35-34.4% | -$4.47-21.8% | -$3.92-16.0% | ||
| -$265.25M-92.1% | -$235.74M-81.9% | -$203.4M-63.1% | -$168.64M-52.2% | -$138.05M-41.8% | ||
| -$265.6M-92.2% | -$236.02M-81.9% | -$203.6M-63.0% | -$168.76M-52.1% | -$138.2M-41.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is Disc Medicine profitable?
- Disc Medicine is not currently profitable: it reported a net loss of $241.6M over the trailing twelve months.
- What is Disc Medicine's earnings per share?
- Disc Medicine's diluted EPS over the trailing twelve months is $-6.62.
- Where does Disc Medicine's income statement data come from?
- Every line is extracted from Disc Medicine's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.